Role of autophagy in MHC class I-restricted antigen presentation
- PMID: 29126597
- PMCID: PMC5940586
- DOI: 10.1016/j.molimm.2017.10.021
Role of autophagy in MHC class I-restricted antigen presentation
Abstract
Major histocompatibility complex (MHC) class I molecules present peptide antigens to MHC class I-restricted CD8+ T lymphocytes. The peptides loaded onto MHC class I molecules are typically derived from cytosolic antigens, which includes both self and foreign proteins. In addition to this classical MHC class I antigen presentation pathway, some cell types, especially dendritic cells can present antigens from exogenous sources to MHC class I-restricted CD8+ T cells, in a process called cross-presentation. A variety of cellular processes, including endocytosis, vesicle trafficking, and autophagy, play critical roles in these antigen presentation pathways. In this review article, we discuss the role of autophagy, an intracellular degradation system that delivers cytoplasmic constituents to lysosomes, in MHC class I-restricted antigen presentation. A mechanistic understanding of the role of autophagy-related proteins in MHC class I restricted antigen presentation may guide future efforts in manipulating autophagy to prevent or treat human disease.
Keywords: Antigen presentation; Autophagy; Autophagy-related proteins; CD8(+) T cells; MHC class I; Vps34.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Similar articles
-
Autophagy and MHC-restricted antigen presentation.Mol Immunol. 2018 Jul;99:163-170. doi: 10.1016/j.molimm.2018.05.009. Epub 2018 May 19. Mol Immunol. 2018. PMID: 29787980 Review.
-
Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α+ dendritic cells.Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6371-E6380. doi: 10.1073/pnas.1706504114. Epub 2017 Jul 17. Proc Natl Acad Sci U S A. 2017. PMID: 28716903 Free PMC article.
-
Alternative pathways for MHC class I presentation: a new function for autophagy.Cell Mol Life Sci. 2011 May;68(9):1533-41. doi: 10.1007/s00018-011-0660-3. Epub 2011 Mar 10. Cell Mol Life Sci. 2011. PMID: 21390546 Free PMC article. Review.
-
Differential use of autophagy by primary dendritic cells specialized in cross-presentation.Autophagy. 2015;11(6):906-17. doi: 10.1080/15548627.2015.1045178. Autophagy. 2015. PMID: 25950899 Free PMC article.
-
Involvement of autophagy in MHC class I antigen presentation.Scand J Immunol. 2020 Nov;92(5):e12978. doi: 10.1111/sji.12978. Epub 2020 Oct 19. Scand J Immunol. 2020. PMID: 32969499 Free PMC article. Review.
Cited by
-
The significance of targeting lysosomes in cancer immunotherapy.Front Immunol. 2024 Feb 2;15:1308070. doi: 10.3389/fimmu.2024.1308070. eCollection 2024. Front Immunol. 2024. PMID: 38370407 Free PMC article. Review.
-
Dendritic cell PIK3C3/VPS34 controls the pathogenicity of CNS autoimmunity independently of LC3-associated phagocytosis.Autophagy. 2022 Jan;18(1):161-170. doi: 10.1080/15548627.2021.1922051. Epub 2021 May 7. Autophagy. 2022. PMID: 33960279 Free PMC article.
-
Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis.Commun Biol. 2022 May 19;5(1):480. doi: 10.1038/s42003-022-03387-9. Commun Biol. 2022. PMID: 35590096 Free PMC article.
-
HIV-1 Nef counteracts autophagy restriction by enhancing the association between BECN1 and its inhibitor BCL2 in a PRKN-dependent manner.Autophagy. 2021 Feb;17(2):553-577. doi: 10.1080/15548627.2020.1725401. Epub 2020 Feb 25. Autophagy. 2021. PMID: 32097085 Free PMC article.
-
Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges.Acta Pharm Sin B. 2024 Sep;14(9):3818-3833. doi: 10.1016/j.apsb.2024.05.013. Epub 2024 May 13. Acta Pharm Sin B. 2024. PMID: 39309492 Free PMC article. Review.
References
-
- Backer JM. The intricate regulation and complex functions of the class III phosphoinositide 3-kinase Vps34. Biochem J. 2016;473:2251–2271. - PubMed
-
- Baghdadi M, et al. TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance. Immunity. 2013;39:1070–1081. - PubMed
-
- Bevan MJ. Cross-priming. Nat Immunol. 2006;7:363–365. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials